Startups channel feed – Endpoints News

Startups channel feed

Startup making software for pharma manufacturing industry nets $12M+ Series A

3 years ago

'As the market has turned': Enveda secures $68M to move revised pipeline into the clinic in 2023

3 years ago

Scoop: A2 Biotherapeutics raises $62M for solid tumor cell therapies

3 years ago

Scoop: As Sio closes, former CEO from ‘vant exit finds himself at helm of Irv Weissman stealth biotech

3 years ago

Scoop: Moderna co-founder's regenerative medicine biotech nabs funds, but loses Genentech

3 years ago

Flagship plants next bet on chronic diseases with ex-Ancestry CEO at the helm

3 years ago

Scoop: Stephen Squinto’s Yale spinout is raising a Series B for genetic medicines

3 years ago

Amgen vet's new biotech nets $47M Series A for polymer-based ADCs

3 years ago

Priming therapy biotech emerges from stealth with seed funding — and on a hunt for partners

3 years ago

Scoop: Avalon, MPM back new CNS biotech with scientific chops from Astellas

3 years ago

A new Vega enters the galaxy with bleeding disorder antibody set for 2023 trial

3 years ago

Entact Bio makes its Series A debut with $81M to launch protein enhancement platform

3 years ago

Pfizer-backed Mediar Therapeutics ropes in another Big Pharma investor

3 years ago

Vertex-partnered gene therapy biotech Affinia scraps IPO plans

3 years ago

Salarius Pharmaceuticals sees withdrawals, 3 of 13 patient responders in sarcoma trial

3 years ago

A fledgling biotech goes SPAC route to bankroll cancer vaccine, CAR-T and CD47

3 years ago

CRO startup Vial scores $67M Series B led by General Catalyst

3 years ago

Lundbeck-partnered preclinical biotech nabs Series A from AstraZeneca

3 years ago

Cajal Neuroscience launches with $96M Series A, tackling Alzheimer's and Parkinson's

3 years ago

Lilly joins in expanded Series A round for BeiGene-partnered mRNA biotech

3 years ago

Scoop: Versant, NEA launch new biotech helmed by ex-CEO of protein degrader C4 Therapeutics

3 years ago

German biotech CatalYm raises $50M to flip weight loss target for cancer

3 years ago

Simulations for experiments: Bayer-backed startup lands $20M to test out its tech

3 years ago

Maker of new gene therapy vector launches its second company, looking to zero in on rare skin conditions

3 years ago

First page Previous page 34 35 363738 39 40 Next page Last page